Allergic contact dermatitis of both eyes caused by alcaftadine 0.25%: a case report
Abstract Background To report the first case of allergic contact dermatitis (ACD) associated with alcaftadine 0.25% ophthalmic solution. Case presentation The patient was a 51-year-old woman with no previous history of side effects to ophthalmic antihistamine agents. She had been prescribed alcaftad...
Main Authors: | Jae Hyuk Kim, Hyun Joon Kim, Sun Woong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-019-1166-2 |
Similar Items
-
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
by: Lakshey Dudeja, et al.
Published: (2019-01-01) -
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
by: Shruti Ayyappanavar, et al.
Published: (2021-01-01) -
The Prevalence of Allergic Rhinitis, Allergic Conjunctivitis, Atopic Dermatitis and Asthma among Adults of Tehran
by: Raheleh SHOKOUHI SHOORMASTI, et al.
Published: (2018-11-01) -
The Role of Leukotriene B4 in Allergic Diseases
by: Hiroshi Ohnishi, et al.
Published: (2008-01-01) -
Allergic Conjunctivitis
by: Muhammed Vally, et al.
Published: (2017-11-01)